Advertisement
News
Subscribe to MDT Magazine News

AACR Congratulates William S. Dalton on 2010 Leadership in Personalized Medicine Award

October 21, 2010 11:32 am | by AACR | Comments

PHILADELPHIA — The American Association for Cancer Research expresses its congratulations to and appreciation of William S. Dalton, M.D., Ph.D., who will receive the 2010 Leadership in Personalized Medicine Award from the Personalized Medicine Coalition (PMC). Dalton, who has been a...

TOPICS:

Rhythmlink International Announces Change in Engineering Management

October 21, 2010 11:32 am | by Bio-Medicine.Org | Comments

COLUMBIA, S.C., Oct. 21 /- Engineering executive Harold Kaefer has been named Rhythmlink's new director of engineering. With over 20 years of experience within the medical device, diagnostic and laser industries, Mr. Kaefer will provide project and engineering management to Rhythmlink's...

TOPICS:

Dicerna makes $29M second close on Series B funding round

October 21, 2010 10:33 am | by Mass High Tech: The Journal of New England Technology | Comments

Dicerna Pharmaceuticals Inc. has added $4 million in a second close of its Series B financing, bringing the round to $29 million, with the add-on funding backed by new investor SR One.

Advertisement

Vishay introduces new 500V N-channel power MOSFETs

October 21, 2010 10:33 am | by I-Micronews | Comments

Vishay Intertechnology, Inc. released four new 500V, 16A n-channel power MOSFETs with ultra-low 0.38Ω maximum on-resistance at a 10V gate drive, and an improved gate charge of 68nC, in the TO-220AB,TO-220 FULLPAK, D²PAK, and TO-247AC packages.

Hitachi and Johnson controls announce plans to collaborate on advanced energy storage

October 21, 2010 10:33 am | by I-Micronews | Comments

Hitachi, Ltd. and Johnson Controls, Inc. announced that they have signed a memorandum of understanding to work together on several fronts in the field of advanced energy storage.

Invirase (saquinavir): Label Change - Risk of Abnormal Heart Rhythm

October 21, 2010 10:32 am | by U.S. Food & Drug Administration | Comments

Prolonged QT or PR intervals reported when Invirase is used with the antiviral medication, Norvir (ritonavir).

CareFusion Will Host an Earnings Conference Call on Nov. 2 to Discuss the Results for the First Quarter Fiscal 2011

October 21, 2010 9:33 am | by Bio-Medicine.Org | Comments

SAN DIEGO, Oct. 21 /- CareFusion (NYSE: CFN ), a leading, global medical device company, today announced plans to release first quarter fiscal 2011 results on Tuesday, Nov. 2 before the start of trading on the New York Stock Exchange. (Logo:  ...

TOPICS:

Span-America Announces Fourth Quarter and Fiscal Year-End 2010 Conference Call on the Internet

October 21, 2010 9:33 am | by Bio-Medicine.Org | Comments

GREENVILLE, S.C., Oct. 21 /- Span-America Medical Systems, Inc. (Nasdaq:  SPAN) will provide an online, real-time webcast and rebroadcast of its conference call on Tuesday, November 2, 2010, covering results for the fourth quarter and fiscal year-end 2010, which will be released...

TOPICS:
Advertisement

VirtualScopics Schedules Third Quarter 2010 Earnings Announcement

October 21, 2010 9:32 am | by Bio-Medicine.Org | Comments

ROCHESTER, N.Y., Oct. 21 /- VirtualScopics, Inc. (Nasdaq: VSCP ), a leading provider of quantitative imaging for clinical trials, announced today that before the market opens on Thursday, November 11, 2010 it will release its third quarter 2010 financial results. The company will host a...

TOPICS:

Merlot OrthopediX Enters into Exclusive Global Agreement with Alphatec Spine to Develop and Market Merlot's Bone Anchorage Technology for the Treatment of Spine Disorders

October 21, 2010 8:33 am | by Bio-Medicine.Org | Comments

CLEVELAND, Oct. 21 /- Merlot OrthopediX, Inc., a Cleveland Clinic spin-off company jointly owned by Cleveland Clinic, Cleveland, OH, Frantz Medical Group, Mentor, OH and Dr. Isador Lieberman, M.D., M.B.A., Texas Back Institute, Plano, Texas, announced today that it has entered into an...

TOPICS:

Actavis Inc. Issues a Voluntary Recall of 18 Lots of Fentanyl Transdermal System 25 mcg/h

October 21, 2010 8:32 am | by Bio-Medicine.Org | Comments

MORRISTOWN, N.J., Oct. 21 /- Actavis Inc. today announced a voluntary recall to the wholesale and retail levels only of 18 lots of Fentanyl Transdermal System 25 mcg/hour C-II patches manufactured for Actavis by Corium International in the United States. Actavis identified one lot of 25...

TOPICS:

Forensic scientists use postmortem imaging-guided biopsy to determine natural causes of death

October 21, 2010 8:32 am | by EurekAlert | Comments

(American College of Radiology / American Roentgen Ray Society) Researchers found that the combination of computed tomography, postmortem CT angiography and biopsy can serve as a minimally invasive option for determining natural causes of death such as cardiac arrest, according to a study...

TOPICS:

AACR Colorectal Cancer Conference to Focus on Screening, New Treatments

October 21, 2010 8:32 am | by AACR | Comments

PHILADELPHIA — The American Association for Cancer Research will hosts its first special conference on Colorectal Cancer: Biology to Therapy from Oct. 27-30, 2010, at the Loews Hotel, Philadelphia.

TOPICS:

<i>Blog: </i>Ozzy Osbourne's DNA, way beyond the need to know

October 21, 2010 7:31 am | by Mass High Tech: The Journal of New England Technology | Comments

MHT Editor James M. Connolly blogs: Knome Inc., the Cambridge genomics company, completed a sequencing of Ozzy Osbourne’s genome. Now, Ozzy and Sharon plan to reveal the results of his test. It’s the technology equivalent of the old line, “You don’t really want to know how the sausages are made.”

Algeta and Lumiphore Announce Global Agreement for the Development of Targeted Alpha-Pharmaceutical Therapeutics

October 21, 2010 5:34 am | by Bio-Medicine.Org | Comments

RICHMOND, Calif., Oct. 21 /- Lumiphore Inc., a biotechnology leader in new proprietary bifunctional metal-chelation technology for use in high-value imaging, diagnostics, and therapeutics and Algeta ASA (OSE:ALGETA), the cancer therapeutics company, announced that they have signed a...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading